KCNT1 inhibitor (Praxis/UCB)

N/A

Report date: 2025/01/26 17:08:45
NME

Base Information

Drug NameKCNT1 inhibitor (Praxis/UCB)
Drug Alias Nameantisense oligonucleotide (Praxis)PRX-2904
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionPotassium Sodium-Activated Channel Subfamily T Member 1 inhibitors
TargetsPotassium Sodium-Activated Channel Subfamily T Member 1
Therapy Area/IndicationsRare DiseasesEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPraxis Precision Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesPraxis Precision Medicines Inc
Inactive CompaniesN/A
Active IndicationsRare DiseasesEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A